Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Metformin Treatment on Surrogate Markers of Ageing in North Indian Individuals With Prediabetes
NCT07302932Completed
- Sponsor
- Diabetes Foundation
- Start
- Feb 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in prediabetes comparing Metformin Group with Placebo Group (2 arms). Primary endpoints: Leukocyte telomere length at 6 months and Telomerase activity at 6 months. Started Feb 2023; status: completed.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT07302932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07302932.